Xeplonerve Injection is a parenteral formulation combining Methylcobalamin (1500 mcg/2 ml), Nicotinamide (100 mg/2 ml), and Pyridoxine Hydrochloride (100 mg/2 ml), designed to support nerve health and treat peripheral neuropathies. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and myelin sheath repair, facilitating improved nerve conduction and reducing neuropathic pain. Nicotinamide, a form of vitamin B3, contributes to cellular energy metabolism and exhibits neuroprotective properties by enhancing neuronal repair mechanisms. Pyridoxine Hydrochloride (vitamin B6) is essential for neurotransmitter synthesis and proper nerve function, preventing neuropathy associated with vitamin B6 deficiency. Xeplonerve Injection is indicated for the management of various neurological disorders including diabetic neuropathy, alcoholic neuropathy, and other peripheral nerve dysfunctions. It is administered intramuscularly or intravenously under medical supervision, ensuring rapid bioavailability and therapeutic efficacy. The combination of these vitamins provides synergistic benefits, promoting nerve repair, reducing symptoms such as numbness, tingling, and burning sensations, and improving overall nerve function. Xeplonerve Injection should be used with caution in patients with hypersensitivity to any components and under appropriate medical guidance to optimize treatment outcomes.